Hecht R - Search Results

1

Cohen SL, Halaas JL, Friedman JM, Chait BT, Bennett L, Chang D, Hecht R, Collins F. Cohen SL, et al. Among authors: hecht r. Nature. 1996 Aug 15;382(6592):589. doi: 10.1038/382589a0. Nature. 1996. PMID: 8757126 No abstract available.

2

Effects of the obese gene product on body weight regulation in ob/ob mice.

Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Pelleymounter MA, et al. Among authors: hecht r. Science. 1995 Jul 28;269(5223):540-3. doi: 10.1126/science.7624776. Science. 1995. PMID: 7624776

3

Megakaryocyte growth and development factor and interleukin-3 induce patterns of protein-tyrosine phosphorylation that correlate with dominant differentiation over proliferation of mpl-transfected 32D cells.

Mu SX, Xia M, Elliott G, Bogenberger J, Swift S, Bennett L, Lappinga DL, Hecht R, Lee R, Saris CJ. Mu SX, et al. Among authors: hecht r. Blood. 1995 Dec 15;86(12):4532-43. Blood. 1995. PMID: 8541543 Free article.

4

Efficacy of exogenous recombinant murine leptin in lean and obese 10- to 12-mo-old female CD-1 mice.

Pelleymounter MA, Cullen MJ, Healy D, Hecht R, Winters D, McCaleb M. Pelleymounter MA, et al. Among authors: hecht r. Am J Physiol. 1998 Oct;275(4):R950-9. doi: 10.1152/ajpregu.1998.275.4.R950. Am J Physiol. 1998. PMID: 9756522

5

Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice.

Hokom MM, Lacey D, Kinstler OB, Choi E, Kaufman S, Faust J, Rowan C, Dwyer E, Nichol JL, Grasel T, Wilson J, Steinbrink R, Hecht R, Winters D, Boone T, Hunt P. Hokom MM, et al. Among authors: hecht r. Blood. 1995 Dec 15;86(12):4486-92. Blood. 1995. PMID: 8541537 Free article.

6

Preparative electrofocusing for industrial applications.

Hecht R, Tressel T, Goldshteyn V, Winters D, Wilson J, Boone T, Daniels M. Hecht R, et al. Prep Biochem Biotechnol. 1996 Aug-Nov;26(3-4):201-16. doi: 10.1080/10826069608000066. Prep Biochem Biotechnol. 1996. PMID: 8958569

7

Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes.

Hecht R, Li YS, Sun J, Belouski E, Hall M, Hager T, Yie J, Wang W, Winters D, Smith S, Spahr C, Tam LT, Shen Z, Stanislaus S, Chinookoswong N, Lau Y, Sickmier A, Michaels ML, Boone T, Véniant MM, Xu J. Hecht R, et al. PLoS One. 2012;7(11):e49345. doi: 10.1371/journal.pone.0049345. Epub 2012 Nov 27. PLoS One. 2012. PMID: 23209571 Free PMC article.

8

A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys.

Stanislaus S, Hecht R, Yie J, Hager T, Hall M, Spahr C, Wang W, Weiszmann J, Li Y, Deng L, Winters D, Smith S, Zhou L, Li Y, Véniant MM, Xu J. Stanislaus S, et al. Among authors: hecht r. Endocrinology. 2017 May 1;158(5):1314-1327. doi: 10.1210/en.2016-1917. Endocrinology. 2017. PMID: 28324011

9

Comparison of the biophysical characteristics of human brain-derived neurotrophic factor, neurotrophin-3, and nerve growth factor.

Narhi LO, Rosenfeld R, Talvenheimo J, Prestrelski SJ, Arakawa T, Lary JW, Kolvenbach CG, Hecht R, Boone T, Miller JA, et al. Narhi LO, et al. Among authors: hecht r. J Biol Chem. 1993 Jun 25;268(18):13309-17. J Biol Chem. 1993. PMID: 8514769 Free article.

10

A novel anion-exchange resin suitable for both discovery research and clinical manufacturing purposes.

Porat A, Winters D, Cai L, Smith S, Abroson F, Tam LT, Shen Z, Hecht R. Porat A, et al. Among authors: hecht r. Prep Biochem Biotechnol. 2012;42(4):304-21. doi: 10.1080/10826068.2012.654570. Prep Biochem Biotechnol. 2012. PMID: 22708809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters